期刊文献+

蛋白激酶Cβ介导急性股动脉损伤后基质金属蛋白酶9的活化 被引量:6

Protein kinase Cβ-mediated matrix metalloproteinase 9 activation by acute femoral artery injury
原文传递
导出
摘要 目的观察急性内皮剥脱损伤对血管壁基质金属蛋白酶(matrix metalloproteinase,MMP)9的活化及其可能的信号调控机制。方法以C57BL/6小鼠为研究对象,实施股动脉内皮剥脱损伤后,分别制备股动脉总蛋白和膜蛋白提取液,用明胶酶谱法检测MMP9活性,蛋白质印迹(Western Blot)检测MMP9抗原表达和膜蛋白中蛋白激酶c(protein kinaseC,PKc)多种异构体的表达水平;并以PKc8抑制剂Ruboxistaurin预处理小鼠72h后,观察急性血管损伤对MMP9表达的影响。结果内皮剥脱损伤4~24h,小鼠股动脉MMP9活性增加,最大诱导表达量在损伤后8h,为对照组的(99.33±9.50)倍(F=51.49,P〈0.01);MMP9抗原表达与其活性呈现平行变化。内皮剥脱损伤15~120min,股动脉膜蛋白提取液中PKCβⅡ被快速诱导表达,30min时达最大值,为对照组的(7.50±0.60)倍(F=207.06,P〈0.01)。PKCβ抑制剂Ruboxistaurin可减少血管损伤诱导的MMP9活化(F=53.96,P〈0.01)。结论在小鼠股动脉内皮剥脱模型中,MMP9活化至少部分由PKCβ信号所介导,阻断PKCβ信号通路可望成为抑制血管损伤后MMP9过度活化的干预靶点。 Objective To investigate the activation of matrix metalloproteinase (MMP)9 by acute arterial injury and the involved signaling mechanism in murine femoral artery. Methods In the C57BL/6 mice femoral artery denudation injury were performed. Total protein and membrane protein extracts were prepared from targeted arteries. The MMP 9 activity was measured by zymography assay, the expressions of MMP 9 antigen and protein kinase C (PKC) isoforms were measured by Western blot. Seventy-two hours after mice fed with PKCβ inhibitor (ruboxistaurin), the denudation injury triggered MMP 9 activation was reassessed. Results Within 4-24 hours after denudation injury, MMP 9 activity in femoral arteries was significantly increased, with a peak induction of (99.3± 9.5) times the sham control (F=51.49,P〈0.01) at 8 h. MMP 9 antigen increased in parallel with MMP 9 activity. Within 15-120 minutes after denudation injury, there was a significant induction of PKCβⅡin membrane fraction of femoral arteries, with a maximum induction of (7.50±0.60) times the sham control (F=207.06,P〈0.01)at 30 min. Injury-induced MMP 9 activation was significantly inhibited by ruboxistaurin. Conclusions MMP 9 activation is, at least in part, mediated by PKCβ in acute arterial denudation injury, it highlights the new target for therapeutic intervention to suppress the over-activation of MMP 9, which plays a critical role in restenosis.
作者 吴文伟 黄春
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2011年第7期589-592,共4页 Chinese Journal of Geriatrics
基金 福建省医学创新课题(2009CXB-18) 福建省教育厅课题(JA07103)
关键词 蛋白激酶C 基质金属蛋白酶9 内皮 血管 Protein kinase C-delta Matrix metalloproteinase 9, Endothelium, vascular
  • 相关文献

参考文献8

  • 1Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Phamacol, 2008, 75: 346-359. 被引量:1
  • 2Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res, 2003, 92: 827-839. 被引量:1
  • 3Katsaros KM, Kastl SP, Zorn G, et al. Increase restenosis rate after implantation of drug-eluting stents in patients with elevated serum activity of matrix metalloproteinase 2 and -9. JACC Cardiovasc Interv, 2010, 3: 90-97. 被引量:1
  • 4Ge JB, Shen CX, Liang C, et al. Elevated matrix metalloproteinase expression after stent implantation is associated with restenosis. Int J Cardiol, 2006, 112: 85-90. 被引量:1
  • 5Roque M,John T, Juan FJ, et al. Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vascr Biol, 2000,20 : 335-342. 被引量:1
  • 6Scott NA. Restenosis following implantation of bare metal coronary stents: pathophysiology and pathways involved in the vascular response to injury. Adv Drug Deliv Rev, 2006,58: 358-376. 被引量:1
  • 7Li C, Wernig F, Leitges M, et al. Mechanical stress-activated PKC delta regulates smooth muscle migration. FASEB J, 2003, 17: 2106-2108. 被引量:1
  • 8Eitges M, Mayr M, Braun U, et al. Exacerbated vein graft arteriosclerosis in protein kinase C delta mice. J ClinInvest, 2001, 108: 1505-1512. 被引量:1

同被引文献36

  • 1YanS F,FujitaT,Lu J,etal. Egr-1, a master switch coordi- nating regulation of divergent gene families underlying ischemic stress[J]. ,NutMed, 2000,6(12):1355-1361. 被引量:1
  • 2Zeng S,Dun H,Ippagunta N,etal. Receptor for advancedgly- cation end product (RAGE)-dependent modulation of early growth response-1 in hepatic isehemia/reperfusion injury [J]. J Hepatol, 2009,50(5):929 936. 被引量:1
  • 3Fujita T, Asai T, Andrassy M,et al. PKCbeta regulates ische- mia/reperfusion injury in the lung[J]. J Clin Invest, 2004, 113(11) : 1615-1623. 被引量:1
  • 4Huang C,Chang J S,Xu Y,et al. Reduction of PKCbetaII ac- tivity in smooth muscle ceils attenuates acute arterial injury [J]. Atherosclerosis, 2010,212(1) ..123-130. 被引量:1
  • 5Ramasamy R, Yan S F, Schmidt A M. Receptor for AGE (RAGE) signaling mechanisms in the pathogenesis of diabe- tes and its complications [J]. N Y Acad Sci, 2011, 1243: 88-102. 被引量:1
  • 6Kobayashi M, Inoue K,Warabi E, et al. A simple method of isolating mouse aortic endothelial cells [J]. J Atheroscler Thromb, 2005,12(3) :138 142. 被引量:1
  • 7Kong L H, Andrassy M, Chang J S,et al. PKC1] modulates ischemia-reperfusion injury in the heart[J]. Am J PhysiolHeart Circ Physiol, 2008,294 : 1862-1870. 被引量:1
  • 8Bhindi R,Fahmy R G,McMahon A C,et al. Intracoronary de livery of DNAzymes targeting human EGR-1 reduces infarct size following myocardial ischaemia reperfusion[J]. J Pathol, 2012,227(2), 157-164. 被引量:1
  • 9Ramasamy R,Schmidt A M. Receptor for advanced glycation end products(RAGE) and implications for the pathophysiolo- gy of heart failure[J]. Curt Heart Fail Rep, 2012,9 (2) 107-116. 被引量:1
  • 10Geroldi D, Falcone C, Emanuele E. Soluble receptor for ad vanced glycation end products: from disease marker to poten tial therapeutic target [J]. Curt Med Chem, 2006,13 (17) 1971-1978. 被引量:1

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部